Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer

Figure 3

(A) RAD001 inhibits proliferation of gastric cancer cells. Gastric cancer cells were treated with the indicated concentrations of RAD001 in the presence of 10% FBS for 48 h. Cell viability was assessed by MTT assay. (B) Phosphorylation of p70s6K was significantly decreased in a dose-dependent manner in both AGS and BGC823 cells by the treatment with RAD001. Both cell lines were incubated with increasing dose of RAD001 for 48 hrs, cell lysates were subjected to western blot analysis with phosphorylated p-S6K and S6K antibodies.

Back to article page